Sort by
Keyphrases
Ovarian Cancer
100%
Nanotechnology
100%
Suicide Gene Therapy
100%
Recurring
100%
Cancer Initiating Cells
100%
Ovarian Tumor
60%
Tumor
60%
Xenograft
40%
Suicide Gene
40%
Cancer Cells
40%
Patient Survival Rate
40%
Primary Tumor
40%
Targeting Mechanism
20%
Cancer Patients
20%
Reporter Gene
20%
High Mortality Rate
20%
Anticancer Activity
20%
Ovarian Cancer Cells
20%
Targeting Vector
20%
Tumor Cells
20%
Therapy Response
20%
Metastatic Spread
20%
Syngeneic
20%
Extracellular Proteins
20%
Targeted Therapeutics
20%
Cisplatin
20%
Therapeutic Agents
20%
Tumor Recurrence
20%
High Efficiency
20%
Leakiness
20%
Multidrug-resistant
20%
Active Targeting
20%
Toxicity Study
20%
Early Treatment
20%
5-year Survival
20%
Animal Tumors
20%
Cancer Relapse
20%
Limiting Distribution
20%
Therapeutic System
20%
Tumor Cell Density
20%
Multidrug Resistance
20%
Minimal Impact
20%
Transcriptional Targeting
20%
Chemotherapy
20%
Nanotechnology Based Systems
20%
Ovarian Cancer Recurrence
20%
Treatment Strategy
20%
Cancer Types
20%
Tumor Site
20%
Enzyme Prodrug
20%
Cancer Stem Cells
20%
Active-passive
20%
Platinum Drugs
20%
Tumor Regression
20%
Prodrug Systems
20%
Pathophysiology
20%
Capillary
20%
Grant Applications
20%
Solid Tumors
20%
In Vivo Biodistribution
20%
Transfect
20%
Passive Targeting
20%
Live Animal Imaging
20%
Gene-directed Enzyme Prodrug Therapy (GDEPT)
20%
System Development
20%
Nanomedicine
20%
Tumor Heterogeneity
20%
Gynecologic Malignancies
20%
Medicine and Dentistry
Ovarian Cancer
100%
Malignant Neoplasm
100%
Neoplasm
57%
Ovarian Tumor
42%
Cancer Cell
42%
Survival Rate
42%
Primary Tumor
28%
Tumor Cell
28%
Cancer Recurrence
28%
Xenograft
28%
Cisplatin
14%
Tumor Recurrence
14%
Multidrug Resistance
14%
Prodrug
14%
Cancer
14%
Cell Density
14%
Biodistribution
14%
Antineoplastic Activity
14%
Tumour Heterogeneity
14%
Tumor Regression
14%
Gene Directed Enzyme Prodrug Therapy
14%
Nanomedicine
14%
Mortality Rate
14%
Pathophysiology
14%
Solid Malignant Neoplasm
14%
Cancer Stem Cell
14%
Treatment Response
14%
Capillary
14%
Reporter Gene
14%
Diseases
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Malignant Neoplasm
100%
Neoplasm
60%
Ovary Tumor
30%
Survival Rate
30%
Primary Tumor
20%
Cancer Recurrence
20%
Biodistribution
10%
Tumor Protein
10%
Prodrug
10%
Cisplatin
10%
Pathophysiology
10%
Nanomedicine
10%
Tumor Regression
10%
Tumor Recurrence
10%
Enzyme Prodrug Therapy
10%
Mortality Rate
10%
Chemotherapy
10%
Solid Malignant Neoplasm
10%
Multidrug Resistance
10%
Diseases
10%